The Medical Board of California meets today and tomorrow near SFO.  Relevant info:

From Dr. Goldstrich:  The medical Board of California quarterly board meeting agenda and all supporting materials can be found at:
On page 103 of this 741 page document, you will see the agenda for Thursday, July 28 and Friday, July 29, 2016. Agenda items which may be of interest to the SCC are:
    •    7G on Thursday afternoon (3:15-5:30 p.m.): Update on the Federation of State Medical Boards
    •    26 on Friday afternoon: Discussion on the Process to Revise the Statement on Marijuana for Medical Purposes, Marijuana Recommendations Guidelines, and a Policy on Physician Use of Marijuana.    
    •    The 50 pages of Supporting Materials for Agenda Item 26 can be found at:
The call-in number for teleconference and comments on Thursday, July 28 is (800) 230-1074
The call-in number on Friday, July 29 is (800) 230-1059
In the past, meetings that I have attended or teleconferenced have usually held to the schedule. From time to time they rearrange the schedule so there’s no guarantee on the order of presentation of items.

From Dr. Robinson:    Some of you may know that the members of the Society of Cannabis Clinicians (SCC) were greatly alarmed by a policy reported in the JAMA, published June 16, by the president of the Federation of State Medical Boards (FSMB) regarding “Medical Board Expectations for Physicians Recommending Marijuana.”

The Medical Board of California, will, at its quarterly meeting in San Francisco, on Friday July 29, discuss these policies and their guidelines concerning physician use of marijuana.  I have also attached the meeting agenda.

I believe there are several provisions, if adopted, would have a disastrous impact on our practice as we know it.  I am inviting you to review the relevant documents (see above) and, if you are so moved, to attend the Medical Board meeting, either IN PERSON or VIA TELECONFERENCE, and make your thoughts known.  This may be one of the rare occasions when members of the Medical Board hear from principled advocates for, and practitioners of, cannabinoid medicine.

A Luta Continua!